Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2 (7): 489-501. 10.1038/nrc839.
Article
CAS
PubMed
Google Scholar
Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005, 24 (50): 7455-7464. 10.1038/sj.onc.1209085.
Article
CAS
PubMed
Google Scholar
Manning BD, Cantley LC: AKT/PKB signaling: navigating downstream. Cell. 2007, 129 (7): 1261-1274. 10.1016/j.cell.2007.06.009.
Article
PubMed Central
CAS
PubMed
Google Scholar
Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, Silliman N, Ptak J, Szabo S, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Lengauer C, Velculescu VE: Colorectal cancer: mutations in a signalling pathway. Nature. 2005, 436 (7052): 792-10.1038/436792a.
Article
CAS
PubMed
Google Scholar
Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ, Lee SH: Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology. 2006, 70 (4): 285-289. 10.1159/000096289.
Article
CAS
PubMed
Google Scholar
Staal SP: Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A. 1987, 84 (14): 5034-5037. 10.1073/pnas.84.14.5034.
Article
PubMed Central
CAS
PubMed
Google Scholar
Liu LZ, Zhou XD, Qian G, Shi X, Fang J, Jiang BH: AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway. Cancer Res. 2007, 67 (13): 6325-6332. 10.1158/0008-5472.CAN-06-4261.
Article
CAS
PubMed
Google Scholar
Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE: A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 2007, 448 (7152): 439-444. 10.1038/nature05933.
Article
CAS
PubMed
Google Scholar
Schuller U, Ruiter M, Herms J, Kretzschmar HA, Grasbon-Frodl E: Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas. Acta Neuropathol. 2008
Google Scholar
Tibes R, Kornblau SM, Qiu Y, Mousses SM, Robbins C, Moses T, Carpten JD: PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation. Br J Haematol. 2008, 140 (3): 344-347. 10.1111/j.1365-2141.2007.06920.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Deng GR: A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer. Nucleic Acids Res. 1988, 16 (13): 6231-10.1093/nar/16.13.6231.
Article
PubMed Central
CAS
PubMed
Google Scholar
Orou A, Fechner B, Utermann G, Menzel HJ: Allele-specific competitive blocker PCR: a one-step method with applicability to pool screening. Hum Mutat. 1995, 6 (2): 163-169. 10.1002/humu.1380060209.
Article
CAS
PubMed
Google Scholar
Tan A, Westerman D, McArthur GA, Lynch K, Waring P, Dobrovic A: Sensitive detection of KIT D816V in patients with mastocytosis. Clin Chem. 2006, 52 (12): 2250-2257. 10.1373/clinchem.2006.068205.
Article
CAS
PubMed
Google Scholar
Bousquet M, Le Guellec S, Quelen C, Rigal-Huguet F, Delsol G, Brousset P: Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations. Hum Pathol. 2006, 37 (11): 1458-1464. 10.1016/j.humpath.2006.05.006.
Article
CAS
PubMed
Google Scholar
Benlloch S, Paya A, Alenda C, Bessa X, Andreu M, Jover R, Castells A, Llor X, Aranda FI, Massuti B: Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn. 2006, 8 (5): 540-543. 10.2353/jmoldx.2006.060070.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brognard J, Clark AS, Ni Y, Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001, 61 (10): 3986-3997.
CAS
PubMed
Google Scholar
VanderWeele DJ, Zhou R, Rudin CM: Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin. Mol Cancer Ther. 2004, 3 (12): 1605-1613.
CAS
PubMed
Google Scholar
Clark AS, West K, Streicher S, Dennis PA: Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther. 2002, 1 (9): 707-717.
CAS
PubMed
Google Scholar
Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, de Gisi S, Malara N, Savino R, Rocco G, Chiappetta G, Franco R, Tirino V, Pirozzi G, Viglietto G: Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung. Cell Cycle. 2007, 7 (5):
Do H, Krypuy M, Mitchell PL, Fox SB, Dobrovic A: High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies. BMC Cancer. 2008, 8: 142-10.1186/1471-2407-8-142.
Article
PubMed Central
PubMed
Google Scholar